Arcutis Biotherapeutics, Inc. ARQT Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s net income?
- Arcutis Biotherapeutics, Inc. (ARQT) reported net income of -$11.3M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s net income changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s net income increased by 54.9% year-over-year, from -$25.06M to -$11.3M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s net income?
- Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s net income has grown at a -12.1% compound annual growth rate (CAGR), from -$206.36M to -$140.04M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.